receptor

(redirected from Fc receptor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Fc receptor: Complement receptor, ADCC
See: receiver
Mentioned in ?
References in periodicals archive ?
Neonatal Fc Receptor blockade by Fc engineering ameliorates arthritis in a murine model.
arms of the antigen presentation pathway, major histocompatibility (MHC) I (B2m) and MHC II (CD74, HLA-DMA, HLA-DMB, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB1) molecules, and three Fc receptors.
TNFa is released by activated inflammatory white blood cells (macrophages) and we have demonstrated that activation of the Fc receptor triggers this release.
There is no evidence that the A face of CRP can bind C1q and an Fc receptor simultaneously, so what is it that controls whether CRP binds C1q or engages an Fc receptor?
PRIMABioMed Limited (Melbourne, Australia), the cancer and immunotherapy research and therapeutic development company, announced that it has received notification from the United States Patent and Trademark Office that it will allow an application relating to the three dimensional (3D) structure of the Fc receptor (FcR), the target of drugs being developed by its subsidiary Arthron Ltd.
In its study of 257 black patients with lupus and 139 without, Salmon's group found that people with the disease are more likely to have inherited a specific version of a gene that codes for a protein called an Fc receptor.
Part Three Half-Life Modulation Involving Recycling by the Neonatal Fc Receptor
DARTs have also been engineered with an Fc domain, which confers them with additional properties, such as Fc receptor binding and extended half-life.
Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain.
We are delighted to receive CTI's ongoing support as Zymeworks continues to build on its recent successes in antibody engineering and especially in the area of Fc receptor specificity.
DARTs also have been engineered with an Fc domain, which confers them with additional properties, such as Fc receptor binding and extended half-life.
Arthron has demonstrated that this Fc receptor may be an important target in the treatment of autoimmune diseases such as rheumatoid arthritis and lupus, and that inhibition of this receptor can alleviate symptoms in several disease models.